Samuel I. Fink, MD, FACP, internal medicine specialist in private practice in Tarzana, California, and his daughter, Sarrica Fink, RN, previously in practice at Cedar Sinai Medical Center…
Jenny C. Yip, PsyD, ABPP, shares advice for HCPs who may be struggling with anxiety or depression as a result of months of practicing medicine and managing personal…
Avraham I. Rivkind, M.D., Head of General Surgery and Shock Trauma Unit at Hadassah University Hospital Ein-Karem discusses the most prominent injury at Hadassah – primary blast lung.…
Avraham I. Rivkind, M.D., Head of the Department of General Surgery and Shock Trauma Unit at Hadassah University Hospital Ein-Karem, discusses new developments at Hadassah in the field…
NEW YORK (Reuters Health) – For patients with diabetes and hypertension, an antihypertensive regimen combining an ACE inhibitor with a calcium channel blocker provides better protection against cardiovascular…
NEW YORK (Reuters Health) – For patients with severe acute exacerbation of chronic obstructive pulmonary disease (COPD), trimethoprim-sulfamethoxazole was just as effective and safe as ciprofloxacin in a…
NEW YORK (Reuters Health) – Despite its widespread use, there is no conclusive evidence that oxygen therapy benefits patients with acute myocardial infarction (AMI), according to a paper…
NEW YORK (Reuters Health) – Intravenous magnesium sulfate infusions may not help patients with acute aneurysmal subarachnoid hemorrhage, according to a study published in the August issue of…
NEW YORK (Reuters Health) – By evaluating risk factors for thromboembolism, physicians can reduce the number of computed tomography (CT) angiograms they order for patients with suspected pulmonary…
NEW YORK (Reuters Health) – Enterally administered probiotic treatment with Lactobacillus rhamnosus GG can cut the rate of ventilator-associated pneumonia (VAP) in high-risk patients, according to pilot study…
NEW YORK (Reuters Health) – Nine times out of 10, patients admitted to a U.S. hospital for acute exacerbation of chronic obstructive pulmonary disease (COPD) are treated initially…
NEW YORK (Reuters Health) – The novel antiarrhythmic agent vernakalant is a safe and effective agent for pharmacologic conversion of recent-onset atrial fibrillation (AF) in hemodynamically stable patients,…
